期刊文献+

纳米血管生成素-2小干扰RNA质粒制备及功能研究 被引量:2

Encapsulation of Ang-2 Small Interfering RNA Shuttle Vector in Poly Lactic Acid /O-carboxy Methylated Chitosan Nanospheres and Its Functional Investigation
下载PDF
导出
摘要 【目的】制备血管生成素-2小干扰RNA(Ang-2siRNA)质粒纳米微粒,并观察其基因转染能力和基因沉默效果。【方法】应用分子克隆的方法构建Ang-2siRNA质粒,将其与聚乳酸、O-羧甲基壳聚糖用水/油/水(W/O/W)双乳化溶剂蒸发法制备纳米微球,扫描电镜观察其形态和粒径。然后转染原代人脐带静脉内皮细胞, 观察纳米Ang-2siRNA微粒干扰Ang-2基因表达的效果及其细胞保护功能。【结果】扫描电镜观察到Ang- 2siRNA纳米微球呈球形和椭球形,粒径150—200 nm,大小分布均匀,包封完整,分散性良好。有较强转基因能力,良好的RNA干扰效果和血管内皮细胞保护功能。【结论】成功制备纳米Ang-2siRNA微粒。并证实其载基因能力和RNA干扰效果,对血管内皮细胞损伤因素有良好保护作用,为进一步研究心肌梗死的血管修复机制奠定了坚实的基础。 [Objective]To prepare Ang-2 small interfering RNA (siRNA) shuttle vector nanosphere and evaluate both its gene-delivery ability and its gene-silence effect. [Methods] The nanosphere was prepared by the solvent evaporation technique with Poly (lactic acid)/O-carboxymethylated and Ang-2 siRNA shuttle vector. The microscopic morphology of the nanosphere was examined by scanning electron microscope. The gene silence effect of nanosphere for transfected human umbilical vein endothelium cells (HUVEC) was observed. [Results] The nanospheres were spherical or ellipse shape. Their diameters were in the range of 150-200 nm. Its gene-delivery and RNA interfering ability were perfect, [Conclusion] We synthesized Ang-2 (siRNA) shuttle vector nanosphere successfully and proved both its gene-delivery ability and its RNAi effect. It laid the foundation vascular renovation about myocardial infarction.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2005年第2期146-150,共5页 Journal of Sun Yat-Sen University:Medical Sciences
基金 卫生部科研基金资助项目(981093)
关键词 ANG-2 SIRNA 纳米微粒 基因载体 制备 功能 Ang-2 siRNA nanosphere gene-delivery system
  • 相关文献

参考文献10

  • 1Chong A, Caine GJ, Lip GY. Angiopoietin/tie-2 as mediators of angiogenesis: a role in congestive heart failure[J]. Eur J Clin Invest, 2004, 34(1):9-13.
  • 2Tsigkos S, Koutsilieris M, Papapetropoulos A.Angiopoietins in angiogenesis and beyond [J]. Expert Opin Investig Drugs, 2003, 12(6):933-41.
  • 3Ye F, Florian M, Magder SA, et al. Regulation of angiopoietin and Tie-2 receptor expression in nonreproductive tissues by estrogen[J]. Steroids, 2002, 67(3-4):305-10.
  • 4Odic D, Kajstum J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium[J]. Nature, 2001,410(6829):701-5.
  • 5Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double2strand RNA in caenorhabditis elegans[J]. Nature, 1998, 391 (6669) :744-5.
  • 6潘仕荣,冯敏.萘普生/聚乙二醇-聚谷氨酸苄酯共聚物纳米胶束[J].中山医科大学学报,2003,24(1):52-57. 被引量:7
  • 7Welin-Berger K, Neelissen JA, Bergenstahl B. The effect of theological behaviour of a topical anaesthetic formulation on the release and permeation rates of the active compound[J]. Eur J Pharm Sci, 2001, 13(3):309-18.
  • 8Xaymardan M, Zheng J, Duignan I, et al. Senescent impairment in synergistic cytokine pathways that provide rapid cardioprotection in the rat heart [J].J Exp Med, 2004, 199(6):797-804.
  • 9Schafer R, Abraham D, Paulus P, et al. Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy [J]. Circulation, 2003, 108(13):1585-91.
  • 10Chen JX, Chen Y, DeBusk L, et al. Dual functional roles of Tie-2/angiopoietin in TNF-alpha-mediated angiogenesis[J]. Am J Physiol Heart Circ Physiol, 2004,287(1):H187-95.

二级参考文献3

  • 1奚念朱.控速释药体系和缓释制剂[J]药学学报,1984(09).
  • 2Jiahorng Liaw,Takao Aoyagi,Kazunori Kataoka,Yasuhisa Sakurai,Teruo Okano. Visualization of PEO-PBLA-Pyrene Polymeric Micelles by Atomic Force Microscopy[J] 1998,Pharmaceutical Research(11):1721~1726
  • 3潘仕荣,黄宁芳,林在峰,周群,施峰.聚L-谷氨酸γ-苄酯合成的改进[J].生物医学工程学杂志,1990,7(4):321-324. 被引量:22

共引文献6

同被引文献16

  • 1张勇,陈维真,谢瑶,高锦辉.雄激素受体三螺旋形成寡核苷酸抗前列腺癌细胞增殖的研究[J].中华核医学杂志,2005,25(2):97-99. 被引量:3
  • 2周嘉嘉,陈汝福,卢红伟,唐启彬,周泉波,张黎明.两亲多糖纳米胶束作为药物缓释载体的制备及释药研究[J].中山大学学报(医学科学版),2006,27(6):667-671. 被引量:14
  • 3何祥梁,叶海宁,何东华,马中富,廖晓星,詹红,熊艳,荆小丽.包裹E1A基因的纳米粒子制备及转染人肺腺癌细胞A549实验研究[J].热带医学杂志,2007,7(6):519-521. 被引量:2
  • 4平其能.现代药剂学[M].北京:中国医药科技出版社,1999. 625-639
  • 5Murakami H, Kobayashi M, Takeuchi H. Preparation of poly (DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method [J]. Int J Pharm, 1999, 187(2) : 143-152.
  • 6Yang AS, Yang L, Liu W, et al. Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: Preparation and in vivo evaluation [J]. Int J Pharm, 2007,331( 1 ) : 123-132.
  • 7Avgoustakis K, Beletsi A, Panagi Z, et al. PLGA- mPEG nanopartieles of eisplatin: in vitro nanopartiele degradation, in vitro drug release and in vivo drug residence in blood properties [J]. J Cont Res, 2002, 79(1-3) : 123-135.
  • 8Cohen-Sacks H, Najajreh Y, Tchaikovski V, et al. Novel PDGFβR antisense encapsulated in polymeric nanoparticles for the treatment of restenosis [J]. Gene Therapy, 2002,9(23) : 1607-1616.
  • 9Panyam J, Zhou WZ, Prabha S, et al. Rapid endolysosomal escape of poly (D, L-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery [J]. FASEB J, 2002, 16(10) : 1217-1226.
  • 10Jan-Paul Flacke,Sanjeev Kumar,Sawa Kostin,H. Peter Reusch,Yury Ladilov.Acidic preconditioning protects endothelial cells against apoptosis through p38- and Akt-dependent Bcl-xL overexpression[J]. Apoptosis . 2009 (1)

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部